Ben K.
Ben K. Gibson, Rochester, NY US
Patent application number | Description | Published |
---|---|---|
20150220537 | System & Method for Constructing, Augmenting & Rendering Multimedia Stories - Systems to manage the collection of multimedia and physical-sensor data automatically strike a balance between resources utilized to perform the collection, and the usefulness of the data recorded. The recorded data may be augmented with additional data or data streams, and the resulting dataset is automatically composited to produce an audience presentation focusing on selected aspects of the full dataset. The same source dataset may be composited differently to produce another presentation with a different purpose, theme or focus. | 08-06-2015 |
Ben K. Seon, Williamsville, NY US
Patent application number | Description | Published |
---|---|---|
20120244147 | COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTS - The present application relates to compositions of chimeric anti-endoglin antibodies and anti-VEGF agents. Another aspect relates to the use of chimeric anti-endoglin antibodies and Bevacizumab. Another aspect relates to the use of the compositions to inhibit VEGF induced sprouting. Another aspect relates to the use of the compositions to inhibit angiogenesis. | 09-27-2012 |
20140044724 | ANTI-ENDOGLIN ANTIBODIES AND KNOCKIN MICE EXPRESSING NOVEL HUMAN/MOUSE CHIMERIC ENDOGLIN - Provided are compositions and methods that relate to prophylaxis and therapy of angiogenesis associated disease and includes novel knockin mice which express novel human/mouse chimeric endoglin, vectors for use in making such mice, and murine embryonic stem cells comprising the novel human/mouse transgene. Also provided are anti-human endoglin monoclonal antibodies (mAbs) which can be used as antiangiogenic agents for prophylaxis or therapy of human tumor angiogenesis and human angiogenesis-associated diseases having excessive vascularization. The mAbs do not cross react with murine endoglin. Also provides are methods for using the anti-human endoglin mAbs for prophylaxis or therapy of human tumor angiogenesis and for angiogenesis-associated diseases having excessive vascularization. | 02-13-2014 |
Ben K. Waidhofer, Folsom, CA US
Patent application number | Description | Published |
---|---|---|
20100036771 | System, method an computer program product for processing automated clearing house (ACH) historical data - A system, method, and computer program product for processing automated clearing house (ACH) historical data is provided. The system includes a storage device, a processor, a reconciler component, a risk management component, a pattern matching component, a distribution component, and a display device. The storage device stores ACH historical data from depository financial institutions (DFI) and an ACH operator. The reconciler component identifies related ACH transactions. The risk management component calculates and displays return exposure. The pattern matching component detects rules violations and sends alerts to the DFIs. The distribution component generates and displays a time distribution of ACH returns. | 02-11-2010 |